Skip Nav Destination
Issues
1 June 2015
-
Cover Image
Cover Image
Nitazoxanide, an FDA-approved antiparasitic agent, causes cell death in spheroids (indicated by the loss of GFP fluorescence), while cells in monolayer culture continue proliferating, as can be seen in the middle panels. In contrast, a standard chemotherapeutic agent, oxaliplatin, has a cytostatic effect in monolayer cells, while spheroids remain largely unaffected (bottom panels). For comparison, untreated controls are shown in top panels. For details, see the article by Senkowski and colleagues on page 1504. - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Highlights
Commentary
Small Molecule Therapeutics
Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma
Deepti Soodgupta; Dipanjan Pan; Grace Cui; Angana Senpan; Xiaoxia Yang; Lan Lu; Katherine N. Weilbaecher; Edward V. Prochownik; Gregory M. Lanza; Michael H. Tomasson
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization
Deborah S. Mortensen; Kimberly E. Fultz; Shuichan Xu; Weiming Xu; Garrick Packard; Godrej Khambatta; James C. Gamez; Jim Leisten; Jingjing Zhao; Julius Apuy; Kamran Ghoreishi; Matt Hickman; Rama Krishna Narla; Rene Bissonette; Samantha Richardson; Sophie X. Peng; Sophie Perrin-Ninkovic; Tam Tran; Tao Shi; Wen Qing Yang; Zeen Tong; Brian E. Cathers; Mehran F. Moghaddam; Stacie S. Canan; Peter Worland; Sabita Sankar; Heather K. Raymon
Large Molecule Therapeutics
Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer
Michele Mondini; Mevyn Nizard; Thi Tran; Laetitia Mauge; Mauro Loi; Céline Clémenson; Delphine Dugue; Pierre Maroun; Emilie Louvet; Julien Adam; Cécile Badoual; Dominique Helley; Estelle Dransart; Ludger Johannes; Marie-Catherine Vozenin; Jean-Luc Perfettini; Eric Tartour; Eric Deutsch
Cancer Biology and Signal Transduction
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans
Grant Eilers; Jeffrey T. Czaplinski; Mark Mayeda; Nacef Bahri; Derrick Tao; Meijun Zhu; Jason L. Hornick; Neal I. Lindeman; Ewa Sicinska; Andrew J. Wagner; Jonathan A. Fletcher; Adrian Mariño-Enriquez
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
Tali Voloshin; Dror Alishekevitz; Limor Kaneti; Valeria Miller; Elina Isakov; Irena Kaplanov; Elena Voronov; Ella Fremder; Moran Benhar; Marcelle Machluf; Ron N. Apte; Yuval Shaked
Chemotherapy-Regulated microRNA-125–HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer
Shigehiro Yagishita; Yu Fujita; Satoru Kitazono; Ryo Ko; Yusuke Nakadate; Takeshi Sawada; Yuka Kitamura; Tatsu Shimoyama; Yoshiharu Maeda; Fumiyuki Takahashi; Kazuhisa Takahashi; Tomohide Tamura; Fumiaki Koizumi
Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
Remco Nagel; Marijke Stigter-van Walsum; Marijke Buijze; Jaap van den Berg; Ida H. van der Meulen; Jasmina Hodzic; Sander R. Piersma; Thang V. Pham; Connie R. Jiménez; Victor W. van Beusechem; Ruud H. Brakenhoff
Companion Diagnostics and Cancer Biomarkers
PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer
Duangmani Thanapprapasr; Rebecca A. Previs; Wei Hu; Cristina Ivan; Guillermo N. Armaiz-Pena; Piotr L. Dorniak; Jean M. Hansen; Rajesha Rupaimoole; Jie Huang; Heather J. Dalton; Rouba Ali-Fehmi; Robert L. Coleman; Anil K. Sood
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition
Sally J. Davis; Karen E. Sheppard; Michael S. Anglesio; Joshy George; Nadia Traficante; Sian Fereday; Maria P. Intermaggio; Usha Menon; Aleksandra Gentry-Maharaj; Jan Lubinski; Jacek Gronwald; Celeste Leigh Pearce; Malcolm C. Pike; Anna Wu; Stefan Kommoss; Jacobus Pfisterer; Andreas du Bois; Felix Hilpert; Susan J. Ramus; David D.L. Bowtell; David G. Huntsman; Richard B. Pearson; Kaylene J. Simpson; Ian G. Campbell; Kylie L. Gorringe
Models and Technologies
Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
Wojciech Senkowski; Xiaonan Zhang; Maria Hägg Olofsson; Ruben Isacson; Urban Höglund; Mats Gustafsson; Peter Nygren; Stig Linder; Rolf Larsson; Mårten Fryknäs
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.